- SID Score
- 6.4/10
- Fair value
- $188.65
- Generated
- Nov 17, 2026
- Model
- claude-haiku-4-5-20251001
International Business Machines Corporation (IBM) is trading at $242.51 with a market capitalization of $290.3 billion, currently trading above its fair value estimate of $188.65. The stock presents a mixed investment picture with analyst consensus favoring a "Buy" rating and an average price target of $293.86, suggesting 21.2% upside potential. However, the company exhibits concerning fundamental metrics with failing grades in both Value (F) and Growth (F) categories, and a modest SID Score of 6.4/10 indicates below-average investment quality. Recent insider buying activity and positive earnings surprises suggest management confidence, though valuation concerns persist.
IBM demonstrates weak fundamental positioning with a P/E ratio of 36.68, which is elevated for a mature technology company and suggests the stock is priced at a premium relative to earnings. The company shows a minimal dividend yield of 0.02%, indicating limited income generation for shareholders despite its large market capitalization. Factor grades reveal significant weaknesses in value investing metrics (F grade) and growth potential (F grade), while profitability (C grade) and dividends (C grade) remain mediocre, suggesting the company operates with moderate efficiency but lacks compelling value or expansion prospects. Recent earnings have shown mixed results, with the latest quarter (2026-10-21) beating EPS estimates at $2.95 versus $2.87, though Q2 2026 missed expectations with actual EPS of $2.93 against estimates of $3.02.
The stock's current price of $242.51 sits above both its 50-day moving average of $238.02 and 200-day moving average of $243.99, though the positioning relative to the longer-term average indicates a slight downtrend or consolidation pattern. The RSI(14) of 43.1 suggests the stock is neither overbought nor oversold, sitting in neutral territory with potential room to move in either direction. The technical setup indicates the stock is consolidating with modest momentum, with the gap between current price and the 50-day MA suggesting limited immediate upside pressure from short-term technicals. The fair value estimate of $188.65 represents a 23.7% discount to current prices, creating significant technical resistance should the stock attempt to reach analyst price targets.
Analyst & Insider Sentiment
Analyst sentiment remains constructively bullish with a consensus "Buy" rating and an average price target of $293.86, implying approximately 21.2% upside from current levels despite valuation concerns. Insider activity in late September 2026 demonstrates notable confidence, with five company insiders purchasing shares including Brown Marianne Catherine (415 shares), Miebach Michael (415 shares), Howard Michelle J (291 shares), Pollack Martha E (268 shares), and Buberl Thomas (444 shares). The aggregate insider purchases totaling approximately 1,833 shares suggest management and board members believe the stock is undervalued at current prices. However, neutral news sentiment and the absence of recent news summary indicate a lack of catalysts driving market enthusiasm, potentially limiting near-term upside movement.
The primary risk lies in the significant valuation disconnect, with IBM trading at $242.51 against a fair value estimate of $188.65, creating substantial downside risk if market sentiment shifts or earnings fail to support premium valuations. The company's poor growth and value grades (both F-rated) indicate structural challenges in competitive positioning, with potential risks from technology sector disruption, competition, and legacy business model concerns. High earnings volatility is evident from recent quarters, with performance fluctuating between beats and misses, creating forecast uncertainty and potential for disappointing guidance revisions. The minimal dividend yield of 0.02% provides limited downside protection, and elevated P/E ratio leaves little margin for error should earnings decline or growth disappoint.
IBM represents a contrarian play suitable only for investors with high risk tolerance and conviction in management's transformation strategy, as the company trades at a substantial premium to intrinsic value with weak fundamental indicators. While analyst price targets suggest 21% upside and insider buying signals confidence, the concerning factor grades (F in Value and Growth) and fair value discount of 23.7% indicate the market may be overpricing near-term expectations. The stock's neutral momentum (RSI 43.1) and position between short and long-term moving averages suggest consolidation rather than breakout potential, favoring patience before accumulation. Conservative investors should await a price decline toward $200-$220 or significant operational improvements before initiating positions, while growth investors should likely seek alternatives given IBM's underwhelming growth prospects relative to the broader technology sector.